Toward automatic prediction of EGFR mutation status in pulmonary adenocarcinoma with 3D deep learning
暂无分享,去创建一个
Bingbing Ni | Wei Zhao | Peijun Wang | Ming Li | Cheng Li | Liang Jin | Yanqing Hua | Pan Gao | Mengdi Xu | Dexi Bi | Jiancheng Yang | Yingli Sun | Xiaoxia Zhu | Bingbing Ni | Peijun Wang | Jiancheng Yang | Y. Hua | Wei Zhao | Yingli Sun | Cheng Li | P. Gao | Ming Li | Dexi Bi | Mengdi Xu | L. Jin | Xiaoxia Zhu
[1] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[2] Sergey Ioffe,et al. Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift , 2015, ICML.
[3] Kilian Q. Weinberger,et al. Densely Connected Convolutional Networks , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[4] Jeffrey W. Clark,et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.
[5] John Quackenbush,et al. Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. , 2017, Cancer research.
[6] Cristiana Maurella,et al. Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma , 2017, Oncotarget.
[7] T. Jiang,et al. MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis , 2017, European Radiology.
[8] Geoffrey E. Hinton,et al. ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.
[9] Jeffrey W. Clark,et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.
[10] Nitish Srivastava,et al. Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..
[11] Andrew Y. Ng,et al. CheXNet: Radiologist-Level Pneumonia Detection on Chest X-Rays with Deep Learning , 2017, ArXiv.
[12] Sebastian Thrun,et al. Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.
[13] Jie Yang,et al. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis. , 2013, Lung cancer.
[14] Geoffrey E. Hinton,et al. Visualizing Data using t-SNE , 2008 .
[15] Peter Schenk,et al. Cell‐Free Plasma DNA‐Guided Treatment With Osimertinib in Patients With Advanced EGFR‐Mutated NSCLC , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[16] Tianhong Li,et al. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Subhashini Venugopalan,et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.
[18] William Pao,et al. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Tianqi Chen,et al. Empirical Evaluation of Rectified Activations in Convolutional Network , 2015, ArXiv.
[20] Steven E. Schild,et al. Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology , 2017 .
[21] Olivier Gevaert,et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. , 2012, Radiology.
[22] Qiong Li,et al. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology. , 2019, Lung cancer.
[23] Yuan Yu,et al. TensorFlow: A system for large-scale machine learning , 2016, OSDI.
[24] Geoffrey E. Hinton,et al. On the importance of initialization and momentum in deep learning , 2013, ICML.
[25] Jian Sun,et al. Delving Deep into Rectifiers: Surpassing Human-Level Performance on ImageNet Classification , 2015, 2015 IEEE International Conference on Computer Vision (ICCV).
[26] Chun-Ming Tsai,et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. Gemma,et al. F1000 highlights , 2010 .
[28] Hao Chen,et al. Automated Pulmonary Nodule Detection via 3D ConvNets with Online Sample Filtering and Hybrid-Loss Residual Learning , 2017, MICCAI.
[29] Tomoko Betsuyaku,et al. Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer , 2018, OncoTargets and therapy.
[30] Jung-Hwan Lim,et al. Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer , 2018, Thoracic cancer.
[31] Paul Baas,et al. Liquid Biopsy for Advanced Non‐Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[32] N. Girard,et al. New driver mutations in non-small-cell lung cancer. , 2011, The Lancet. Oncology.
[33] Stephen M. Moore,et al. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository , 2013, Journal of Digital Imaging.
[34] Mark J. Ratain,et al. Tumour heterogeneity in the clinic , 2013, Nature.
[35] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[36] G. Giaccone,et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. , 2013, The Journal of molecular diagnostics : JMD.
[37] Aaron Klein,et al. Efficient and Robust Automated Machine Learning , 2015, NIPS.
[38] P. J. García Nieto,et al. A new predictive model for the cyanotoxin content from experimental cyanobacteria concentrations in a reservoir based on the ABC optimized support vector machine approach: A case study in Northern Spain , 2015, Ecol. Informatics.
[39] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[40] Bingbing Ni,et al. 3D Deep Learning from CT Scans Predicts Tumor Invasiveness of Subcentimeter Pulmonary Adenocarcinomas. , 2018, Cancer research.
[41] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[42] Y. Liu,et al. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas. , 2016, Clinical lung cancer.
[43] H. Aerts. The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review. , 2016, JAMA oncology.
[44] Chintan Parmar,et al. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non–Small Cell Lung Cancer , 2017, The Journal of Nuclear Medicine.
[45] Lukasz Kaiser,et al. Attention is All you Need , 2017, NIPS.
[46] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[47] L. Schwartz,et al. Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC , 2016, Scientific Reports.
[48] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[49] Hongyi Zhang,et al. mixup: Beyond Empirical Risk Minimization , 2017, ICLR.